Last Update

2016-05-16T00:00:00.000Z

This profile was last updated on .

Is this you? Claim your profile.

Wrong Nicholas Plotnikoff?

Dr. Nicholas P. Plotnikoff

Non-Voting, Non-Executive Chairman

Immune Therapeutics, Inc.

HQ Phone: (888) 613-8802

Get ZoomInfo Grow

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Immune Therapeutics, Inc.

37 North Orange Avenue Suite 607

Orlando, Florida 32801

United States

Company Description

Immune Therapeutics is a specialty pharmaceutical company undergoing a wide range of FDA testing of therapeutic protocols preparatory to the manufacture, commercialization, marketing, and distribution of their patented therapies. ... more

Find other employees at this company (17)

Background Information

Employment History

Founder, Chairman, and Chief Executive Officer

TNI Pharmaceuticals Inc

Education

American Board of Toxicology

Ph.D.

China Medical University

Web References (49 Total References)


Dr. Nicholas ...

www.sec.gov [cached]

Dr. Nicholas Plotnikoff

...
Dr. Nicholas Plotnikoff - Dr. Plotnikoff has served as our non-voting, Non-Executive Chairman of the Board since March 2012. Dr. Plotnikoff has a Ph.D. in Pharmacology and over 20 years' experience in the pharmaceutical industry working in Pharmacology, Toxicology, and Clinical Research. Prior to joining our Board, Dr. Plotnikoff was a Professor of Pharmacology at the University of Illinois Medical Center in Chicago from December 1987 until his retirement in May 2008. Dr. Plotnikoff formed TNI Pharmaceutical, Inc. in 1987, which became a public company in 1991. Dr. Plotnikoff served as its Chief Executive Officer and President for 20 years where he helped develop the immunological effects of MENK. He successfully managed the project teams that developed the new drug applications for Traxene (a Valium-like tranquilizer) and Cylert (a non-amphetamine psychostimulant). Dr. Plotnikoff was responsible for the Phase I and Phase II trials for MENK in HIV/AIDS. In basic research, he was the first to identify the central nervous system effects of hypothalamic releasing factors (brain hormones), resulting in clinical development for treatment of depression and Parkinson's disease. Dr. Plotnikoff has co-authored 25 publications with Dr. Andrew Schally, covering basic research in the field of depression and Parkinson's disease.
...
Dr. Plotnikoff was issued a number of international patents for the use of MENK in HIV/AIDS and cancer, which we acquired in 2012.
...
From 2000 to present, Dr. Shan has worked both in the United States and China on the clinical trials with Dr. Nicholas Plotnikoff involving new immunotherapies for the treatment of cancer.


$reference.title

$reference.hostName [cached]

$reference.text


Board of Directors

www.tnibiotech.com [cached]

Dr. Nicholas Plotnikoff, Non-Executive Chairman ?

...
Dr. Plotnikoff has a Ph.D. in Pharmacology, with over 20 years in the pharmaceutical industry, working in Pharmacology, Toxicology, and Clinical Research. Dr. Plotnikoff was a Professor of Pharmacology at the University of Illinois Medical Center in Chicago. Dr. Plotnikoff played a pioneering role in investigations of the immunological effects of MENK. He also successfully managed the project teams that developed the NDAs on Traxene (Valium-like tranquilizer) and Cylert (non-amphetamine psychostimulant).
In basic research he was the first to identify the central nervous system effects of hypothalamic releasing factors (brain hormones), resulting in their clinical development for treatment of depression and Parkinson's disease. Dr. Plotnikoff co-authored 25 publications with Dr. Andrew Schally covering basic research in the field of depression and Parkinson's disease.
...
Dr. Plotnikoff held a number of international patents for the use of MENK in HIV/AIDS and cancer.


Dr. Nicholas Plotnikoff, ...

www.publicwire.com [cached]

Dr. Nicholas Plotnikoff, Chairman of TNI BioTech, Inc.


Dr. Nicholas Plotnikoff, ...

www.publicwire.com [cached]

Dr. Nicholas Plotnikoff, Chairman of TNI BioTech, Inc.

Similar Profiles

Other People with this Name

Other people with the name Plotnikoff

Gerry Plotnikoff
Selkirk College

Luba Plotnikoff
Oceanside Volunteer Association

Ronald Plotnikoff
University of Newcastle

Tanya Plotnikoff
Viewpost

Leroy Plotnikoff
FortisBC Inc

Browse ZoomInfo's Business Contact Directory by City

Browse ZoomInfo's
Business People Directory

Browse ZoomInfo's
Advanced Company Directory